APP and Alzheimer disease: To further investigate an association between neuronal insulin dysfunction and Aβ accumulation in AD, streptozotocin (STZ), an agent that selectively destroys insulin-secreting pancreatic β cells and thereby causes insulin depletion, has been applied to AD transgenic mice overexpressing mutant human amyloid precursor protein (APP) [5].